Patents by Inventor Susan Allegonda Maria Mulders

Susan Allegonda Maria Mulders has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RNA MODULATING OLIGONUCLEOTIDES WITH IMPROVED CHARACTERISTICS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS
    Publication number: 20220389421
    Abstract: The current invention provides an improved oligonucleotide and its use for treating, ameliorating, preventing, delaying and/or treating a human cis-element repeat instability associated genetic neuromuscular or neurodegenerative disorder.
    Type: Application
    Filed: April 25, 2022
    Publication date: December 8, 2022
    Inventors: Peter Christian DE VISSER, Susan Allegonda Maria MULDERS
  • RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
    Patent number: 11345915
    Abstract: The current invention provides an improved oligonucleotide and its use for treating, ameliorating, preventing, delaying and/or treating a human cis-element repeat instability associated genetic neuromuscular or neurodegenerative disorder.
    Type: Grant
    Filed: October 22, 2019
    Date of Patent: May 31, 2022
    Assignee: VICO THERAPEUTICS B.V.
    Inventors: Peter Christian De Visser, Susan Allegonda Maria Mulders
  • RNA MODULATING OLIGONUCLEOTIDES WITH IMPROVED CHARACTERISTICS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS
    Publication number: 20200149043
    Abstract: The current invention provides an improved oligonucleotide and its use for treating, ameliorating, preventing, delaying and/or treating a human cis-element repeat instability associated genetic neuromuscular or neurodegenerative disorder.
    Type: Application
    Filed: October 22, 2019
    Publication date: May 14, 2020
    Inventors: Peter Christian DE VISSER, Susan Allegonda Maria MULDERS
  • RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Neuromuscular Disorders
    Publication number: 20180066256
    Abstract: The current invention provides an improved oligonucleotide and its use for treating, ameliorating, preventing, delaying and/or treating a human cis-element repeat instability associated genetic neuromuscular or neurodegenerative disorder.
    Type: Application
    Filed: August 14, 2017
    Publication date: March 8, 2018
    Inventors: Peter Christian de Visser, Susan Allegonda Maria Mulders
  • RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
    Patent number: 9745576
    Abstract: The current invention provides an improved oligonucleotide and its use for treating, ameliorating, preventing, delaying and/or treating a human cis-element repeat instability associated genetic neuromuscular or neurodegenerative disorder.
    Type: Grant
    Filed: October 23, 2014
    Date of Patent: August 29, 2017
    Assignee: BIOMARIN TECHNOLOGIES B.V.
    Inventors: Peter Christian de Visser, Susan Allegonda Maria Mulders
  • COMPOUNDS FOR TREATING, DELAYING AND/OR PREVENTING A HUMAN GENETIC DISORDER SUCH AS MYOTONIC DYSTROPHY TYPE I (DMI)
    Publication number: 20170029820
    Abstract: The current invention provides new compounds for treating, delaying and/or preventing a human genetic disorder such as myotonic dystrophy type 1 (DM1), spino-cerebellar ataxia 8 and/or Huntington's disease-like 2 caused by expansions of CUG repeats in the transcripts of DM1/DMPK, SCA8 or JPH3 genes.
    Type: Application
    Filed: April 8, 2016
    Publication date: February 2, 2017
    Inventors: Maria Begoña Aguilera Diez, Peter Christian de Visser, Susan Allegonda Maria Mulders
  • RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Neuromuscular Disorders
    Publication number: 20150148404
    Abstract: The current invention provides an improved oligonucleotide and its use for treating, ameliorating, preventing, delaying and/or treating a human cis-element repeat instability associated genetic neuromuscular or neurodegenerative disorder.
    Type: Application
    Filed: October 23, 2014
    Publication date: May 28, 2015
    Inventors: Peter Christian de Visser, Susan Allegonda Maria Mulders
  • COMPOUNDS FOR TREATING, DELAYING AND/OR PREVENTING A HUMAN GENETIC DISORDER SUCH AS MYOTONIC DYSTROPHY TYPE I (DMI)
    Publication number: 20140045763
    Abstract: The current invention provides new compounds for treating, delaying and/or preventing a human genetic disorder such as myotonic dystrophy type 1 (DM1), spino-cerebellar ataxia 8 and/or Huntington's disease-like 2 caused by expansions of CUG repeats in the transcripts of DM1/DMPK, SCA8 or JPH3 genes.
    Type: Application
    Filed: October 17, 2013
    Publication date: February 13, 2014
    Applicant: PROSENSA TECHNOLOGIES B.V.
    Inventors: Maria Begoña Aguilera Diez, Peter Christian de Visser, Susan Allegonda Maria Mulders